Bora Pharmaceuticals Co Ltd(TW:6472)
NT$403.00+11.50 (+2.94%)
TW:6472
Bora Pharmaceuticals Co Ltd financials statements
NT$403.00
At close:+11.50 (+2.94%)
Bora Pharmaceuticals Co Ltd (6472) Income Statement
Bora Pharmaceuticals Co Ltd Income Statement
Last quarter (Q2 2026), Bora Pharmaceuticals Co Ltd's total revenue was NT$5.89B, an increase of 20.99% from the same quarter last year. In Q2, Bora Pharmaceuticals Co Ltd's net income was NT$555.76M. See Bora Pharmaceuticals Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 19.01B | NT$ 19.25B | NT$ 14.20B | NT$ 10.49B | NT$ 4.90B | |
| NT$ 7.66B | NT$ 7.71B | NT$ 6.99B | NT$ 2.91B | NT$ 1.67B | |
| NT$ 4.37B | NT$ 4.33B | NT$ 1.74B | NT$ 990.60M | NT$ 625.79M | |
| Depreciation and Amortization | NT$ 936.96M | NT$ 1.03B | NT$ 606.29M | NT$ 325.19M | NT$ 210.16M |
| NT$ 4.23B | NT$ 6.46B | NT$ 5.86B | NT$ 2.27B | NT$ 1.29B | |
| NT$ 3.29B | NT$ 3.38B | NT$ 5.25B | NT$ 1.95B | NT$ 1.08B | |
| NT$ 1.98B | NT$ 1.57B | NT$ -1.18B | NT$ -82.17M | NT$ -22.02M | |
| NT$ 5.28B | NT$ 4.95B | NT$ 4.06B | NT$ 1.84B | NT$ 1.02B | |
| NT$ 2.98B | NT$ 3.94B | NT$ 3.03B | NT$ 1.39B | NT$ 749.74M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 23.90 | NT$ 32.14 | NT$ 25.19 | NT$ 11.89 | NT$ 6.45 |
| Diluted EPS | NT$ 23.24 | NT$ 29.87 | NT$ 24.40 | NT$ 11.78 | NT$ 6.43 |
| Weighted Average Shares Outstanding | 124.76M | 122.58M | 120.31M | 117.02M | 93.34M |
| Weighted Average Shares Outstanding (Diluted) | 135.74M | 125.69M | 124.17M | 118.34M | 93.62M |
Currency in TWD
